09/23/2025 | Press release | Distributed by Public on 09/23/2025 13:10
NEWARK, N.J. - Two New Jersey individuals were charged with conspiracy to unlawfully divert oxycodone, a Schedule II controlled substance, Acting U.S. Attorney and Special Attorney Alina Habba announced.
Michael Kiszka, 60, of East Hanover, New Jersey and Gregory Kubina, 50, of Whiting, New Jersey, were charged by complaint with conspiracy to distribute and possess with intent to distribute oxycodone, in violation of Title 21, United States Code, Section 846. On September 11, 2025, they made their initial appearance in federal court before U.S. Magistrate Judge Jessica S. Allen. The defendants were released on a $100,000 unsecured bond.
According to documents filed in this case and statements made in court:
Kiszka and Kubina engaged in a scheme to obtain high-dosage oxycodone pills from several doctors located in New Jersey and sell those pills to street-level drug users. Specifically, Kiszka obtained oxycodone pills directly from certain doctors and purchased oxycodone pills that Kubina obtained from other doctors. Beginning around April 2024, Kiszka and Kubina were responsible for diverting over 10,000 oxycodone pills to street-level drug users.
If convicted, each defendant faces a statutory maximum sentence of twenty years in prison and a $1 million fine.
Acting U.S. Attorney and Special Attorney Habba credited special agents, task force officers, and diversion investigators with the Drug Enforcement Administration (DEA) under the direction of Special Agent in Charge Cheryl Ortiz in Newark, New Jersey, with the investigation.
The government is represented by Assistant U.S. Attorneys Kruti D. Dharia and Jake A. Nasar of the Office's Health Care Fraud and Opioids Abuse Prevention Unit.
The charges and allegations contained in the complaint are merely accusations, and the defendants are presumed innocent unless and until proven guilty.
####
Defense counsel:
Claressa Lowe, Esq., Assistant Federal Public Defender (Gregory Kubina)
Kevin G. Roe, Esq. (Michael Kiszka)